Eiger BioPharmaceuticals, Inc. (EIGR): Price and Financial Metrics

EIGR POWR Grades

• EIGR scores best on the Sentiment dimension, with a Sentiment rank ahead of 70.07% of US stocks.
• The strongest trend for EIGR is in Value, which has been heading up over the past 177 days.
• EIGR's current lowest rank is in the Stability metric (where it is better than 3.3% of US stocks).

EIGR Stock Summary

• Over the past twelve months, EIGR has reported earnings growth of 227.58%, putting it ahead of 92.98% of US stocks in our set.
• The volatility of EIGER BIOPHARMACEUTICALS INC's share price is greater than that of 92.63% US stocks with at least 200 days of trading history.
• Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for EIGR comes in at -129.81% -- higher than that of merely 4.47% of stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to EIGER BIOPHARMACEUTICALS INC are HUMA, IKNA, GSIT, SURF, and SQZ.
• EIGR's SEC filings can be seen here. And to visit EIGER BIOPHARMACEUTICALS INC's official web site, go to www.eigerbio.com.

EIGR Valuation Summary

• In comparison to the median Healthcare stock, EIGR's price/sales ratio is 13.73% lower, now standing at 4.4.
• EIGR's EV/EBIT ratio has moved up 5.8 over the prior 109 months.

Below are key valuation metrics over time for EIGR.

EIGR Growth Metrics

The 5 year cash and equivalents growth rate now stands at 56.59%.
• The 3 year cash and equivalents growth rate now stands at -26.57%.
• The 2 year net cashflow from operations growth rate now stands at -19.84%.

Over the past 33 months, EIGR's revenue has gone up $14,148,000.

The table below shows EIGR's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	14.148	-77.528	-93.406
2022-06-30	13.163	-76.228	-88.518
2022-03-31	11.169	-74.868	-85.808
2021-12-31	12.142	-71.342	-33.917
2021-09-30	8.782	-70.092	-30.955
2021-06-30	5.743	-64.94	-24.412

EIGR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• EIGR has a Quality Grade of F, ranking ahead of 1.43% of graded US stocks.
• EIGR's asset turnover comes in at 0.037 -- ranking 341st of 682 Pharmaceutical Products stocks.
• ATNM, MNOV, and ATRA are the stocks whose asset turnover ratios are most correlated with EIGR.

The table below shows EIGR's key quality metrics over time.